liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action
Uppsala universitet, Integrativ Fysiologi. (Nordquist)
Uppsala universitet, Integrativ Fysiologi.
2008 (English)In: Biologics: Targets & Therapy, ISSN 1177-5475, E-ISSN 1177-5491, Vol. 2, no 3, 441-452 p.Article in journal (Refereed) Published
Abstract [en]

C-peptide has long been thought to be an inert byproduct of insulin production, but it has become apparent, and accepted, that C-peptide has important biological properties. C-peptide displays beneficial effects in many tissues affected by diabetic complications, such as increased peripheral blood flow and protection from renal damage. However, the mechanisms mediating these effects remain unclear. C-peptide interacts with cellular membranes at unidentified sites distinctive of the insulin family of receptors, and signals to multiple targets known to play a role in diabetes and diabetic complications, such as Na(+)/K(+)-ATPase and NOS. In general, the physiological and molecular effects of C-peptide resemble insulin, but C-peptide also possesses traits separate from those of insulin. These basic studies have been confirmed in human studies, suggesting that C-peptide may lend itself to clinical applications. However, the molecular and physiological properties of C-peptide are not completely elucidated, and large clinical studies have not begun. In order to further these goals, we critically summarize the current state of knowledge regarding C-peptide's renal and vascular effects and the molecular signaling of C-peptide.

Place, publisher, year, edition, pages
2008. Vol. 2, no 3, 441-452 p.
Keyword [en]
C-peptide, insulin, diabetes mellitus, nephropathy, vascular, signaling
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-99303DOI: 10.2147/BTT.S3221PubMedID: 19707375OAI: oai:DiVA.org:liu-99303DiVA: diva2:657229
Available from: 2010-03-02 Created: 2013-10-15 Last updated: 2017-12-06

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Authority records BETA

Nordquist, LinaPalm, Fredrik

Search in DiVA

By author/editor
Nordquist, LinaPalm, Fredrik
In the same journal
Biologics: Targets & Therapy
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 27 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf